Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the U.S. FDA has approved Restylane Contour for the correction of temple hollowing in patients over the age of 21.
"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." To anyone else, my skin probably looks perfectly fine—and it is. But somehow, whenever I look in the ...